NANTONG CITY, China, July 8, 2010 (GLOBE NEWSWIRE) -- Sinobiopharma, Inc. ("Sinobiopharma" or the "Company"), (OTCBB:SNBP), an innovative biopharmaceutical products company with primary operations in China, today announced that Harbinger Research, LLC, an independent equity research firm, has initiated analyst research coverage on the Company.
